arrow
L

Louis Boon

University of Edinburgh
H指数:88
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Control of Intestinal Type 3 Immunity by the Unfolded Protein Response Sensor IRE1 in Antigen Presenting Cells

抗原呈递细胞中未折叠蛋白反应传感器IRE1对肠道III型免疫的调控

2026-09-020
OAAI
Synovial lining macrophages form during early postnatal life via fetal-derived CX3CR1+cells and AQP1+intermediates

滑膜衬里巨噬细胞通过胎儿来源的CX3CR1+细胞和AQP1+中间体在出生后早期形成

2026-08-010
OAAI
The unfolded protein sensor IRE1 is essential for homeostatic dendritic cell maturation

未折叠蛋白传感器IRE1对于树突状细胞的稳态成熟至关重要

2026-07-010
PRE
Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-Seq

多组学免疫谱分析:一种基于SEPARATE-Seq的患者相关原位肺癌模型

2026-04-230
OAAI
Allogeneic haematopoietic cell transplantation promotes atherosclerosis in mice via CD8+ T cells

同种异基因造血细胞移植通过CD8+ T细胞促进小鼠动脉粥样硬化

2025-12-010
PRE
Tumor desialylation surpasses anti-PD-L1 checkpoint therapy in restoring anti-tumor immunity in a murine model for colorectal cancer

肿瘤去唾液酸化在恢复结直肠癌小鼠模型中的抗肿瘤免疫方面超越了抗PD-L1检查点疗法

2025-07-070
OAAI
The bispecific antibody targeting VISTA and PD-L1 shows enhanced tumor inhibitory activity in pancreatic, endometrial and breast cancers compared to mono- and combination immune checkpoint blockade

靶向VISTA和PD-L1的双特异性抗体与单药及联合免疫检查点阻断相比,在胰腺癌、子宫内膜癌和乳腺癌中显示出增强的肿瘤抑制作用。

2025-05-090
OA
Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma

黑色素瘤免疫治疗的多表位DC疫苗与黑色素瘤抗原

2025-03-250
OA
Synthetic High-Throughput Microarrays of Peptidoglycan Fragments as a Novel Sero-Diagnostic Tool for Patient Antibody Profiling

合成高通量肽聚糖片段微阵列作为一种新型的血清学诊断工具用于患者抗体谱分析

2025-02-130
PRE
Allogeneic Hematopoietic Cell Transplantation Promotes Atherosclerosis in Mice Driven By Donor CD8+T Cells

异基因造血细胞移植通过供体CD8+T细胞促进小鼠动脉粥样硬化

BLOOD
IF23.1
2024-11-050
PRE
A deep intronic splice-altering AIRE variant causes APECED syndrome through antisense oligonucleotide-targetable pseudoexon inclusion
2024-09-181
PRE
Targeting conserved TIM3+VISTA+ tumor-associated macrophages overcomes resistance to cancer immunotherapy

靶向保守的TIM3 VISTA肿瘤相关巨噬细胞克服了对癌症免疫疗法的抗性

2024-07-196
OAAI
A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma ( vol 30 , pg 1667 , 2024)
2024-07-151
PRE